FILE Picture – Chairmen Sen. Pat Roberts talks before Secretary of Agriculture nominee Sonny Perdue’s testimony at his verification hearing prior to the Senate Agriculture Committee on Capitol Hill in Washington, DC, U.S. March 23, 2017. REUTERS/Aaron P.Within this trial, 16 Finnish sufferers with coeliac disease received the enzyme and 18 provided a placebo. Colon biopsies afterwards demonstrated gluten-induced damage in the placebo group, without development of damage in the combined group taking the enzyme. The Australian product, called GluteGuard, is dependant on a papaya fruit enzyme called caricain. This enzyme offers shown to be effective in coeliac sufferers before. A 2015 research demonstrated adding caricain to loaf of bread dough decreased toxicity to gluten by 90 percent.